Build Generational Wealth with
AlphaMadera's AI-Driven Investment Intelligence

Institutional-grade analytics, real-time data, and AI research tools — built for investors who think in decades, not days.

Ask Compass anything about the market — earnings, filings, or strategy — in plain English.

Real-time institutional data AI that reads filings & transcripts Built for decades, not days
or search any ticker above
Editorial illustration: PRIMARY SUBJECT — this editorial photo illustrates a story about State Street SPDR S&P 500 ETF, a Asset Management compa
AlphaBlog

Markets Want Details, Not Summit Theater

Stocks are modestly higher as investors lean into the Trump-Xi meeting as a de-escalation setup. The real question is whether next week brings tariff and export-control changes that alter cash flows, not just headlines.

Read more →

Market News

America has GRAVE concerns with China: Former US ambassador to China

America has GRAVE concerns with China: Former US ambassador to China

Former U.S. Ambassador to China Gary Locke discusses President Donald Trump's meeting with Chinese President Xi Jinping on 'The Claman Countdown.' #foxbusiness #fox #media #breakingnews #us #usa #new #news #breaking #theclamancountdown #china #economy #trade #business #politics #political #politicalnews #government #trump #donaldtrump #xi #xijinping #garylocke #diplomacy #global #markets #tariffs #security #uschina #geopolitics

Sep 25, 2026 01:00 PM • youtube.com
Prime: A Buy Due To BLA Filing H1 '27 And Continued PM647 Advancement

Prime: A Buy Due To BLA Filing H1 '27 And Continued PM647 Advancement

Prime Medicine, Inc. maintains a Buy rating, supported by an advancing prime editing pipeline and multiple upcoming clinical catalysts. PM359 is positioned for a potential BLA submission for CGD in 1H 2027, leveraging RMAT and other regulatory designations. Initial clinical data from global phase 1/2 studies of PM577a [WD] and PM647 [AATD] are expected in 2027, targeting significant market opportunities.

Sep 25, 2026 12:00 PM • seekingalpha.com

Stock News